UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
S S S- S0 S1 S2 S3 S4 S5 S6 S7 S8 S9 SA SB SC SD SE SF SG SH SI SJ SK SL SM SN SO SP SQ SR SS ST SU SV SW SY
ST ST- ST1 ST5 ST7 STA STC STD STE STF STI STL STN STO STR STT STU STY
selected terms: 1,016 page 1 of 11

1. (-) Strand ssRNA Virus
[A single stranded RNA virus where the RNA strand is the complement of a mRNA. ( NCI )] (UMLS (NCI) C1093214) Negative Sense ssRNA Virus;
Negative Strand ssRNA Virus;
ssRNA Virus, (-) Strand =Virus ;
51. 4
[After a treatment has been approved and is being marketed, it is studied in a phase IV trial to evaluate side effects that were not apparent in the phase III trial. Thousands of people are involved in a phase IV trial. ( NCI )] (UMLS (NCI) C0282462) study IV =Research Activity ;
=clinical trial;
2. (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
[A propanolamine derivative and a non-selective beta-adrenergic antagonist with antihypertensive property. Timolol competitively binds to beta-1-adrenergic receptors in the heart and vascular smooth muscle and beta-2-receptors in the bronchial and vascular smooth muscle, resulting in a decrease in beta-adrenergic stimulation. Beta-1-receptor blockade results in a decrease in resting and exercise heart rate and cardiac output, a decrease in both systolic and diastolic blood pressure, and, possibly, a reduction in reflex orthostatic hypotension. Beta-2-blockade results in an increase in peripheral vascular resistance. The ultimate results include vasodilation, and negative chronotropic and inotropic cardiac effects. In addition, timolol reduces intra-ocular pressure possibly by decreasing aqueous humor production by reduction of blood flow to the ciliary processes and cAMP synthesis. ( NCI )] (UMLS (NCI) C0040233) =Organic Chemical; Pharmacologic Substance =Propanolamines;
[CV100] BETA-BLOCKERS/RELATED;
[OP101] BETA-BLOCKERS, TOPICAL OPHTHALMIC;
[OP109] ANTIGLAUCOMA, OTHER =TIMOLOL MALEATE;
TIMOLOL HEMIHYDRATE;
TIMOLOL MALEATE;
TIMOLOL HEMIHYDRATE;
52. ST 638
[A tyrosine kinase inhibitor that inhibits phospholipase D activity in human neutrophils at a site between the receptor and phospholipase. (NCI) ( NCI )] (UMLS (NCI) C0075143) =Organic Chemical; Pharmacologic Substance ;
3. (S)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole
[oral imidazole used as an anthelminthic, effective against roundworms, hookworms and strongyloids; also an immunopotentiator; has been used to stimulate immune response in cancer. ( CSP )] (UMLS (NCI) C0023556) =Organic Chemical; Pharmacologic Substance =Anthelminthics;
imidazole;
thiazole;
[AN400] ANTINEOPLASTIC ADJUVANTS =LEVAMISOLE 50 MG
53. ST-52
(UMLS (NCI) C0919271) =Steroid; Pharmacologic Substance ;
4. (S)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole Monohydrochloride
[The chloride salt form of the anthelmintic drug levamisole. Co-administered with fluorouracil in the treatment of Dukes' stage C colon cancer, levamisole restores immune function through stimulating antibody formation, enhancing T-cell activity, and potentiating macrophage function. (NCI04) ( NCI )] (UMLS (NCI) C0733383) Cloridrato de Levamizol;
LEVAMISOLE HYDROCHLORIDE;
l-Tetramisole Hydrochloride;
=Organic Chemical; Pharmacologic Substance
54. St. Croix Chippewa Indians of Wisconsin, St. Croix
(UMLS (HL7) C1554505) =Population Group =NativeEntityContiguous;
5. 1
[The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments. ( NCI )] (UMLS (NCI) C0920321) clinical trial phase I;
Clinical Trials, Phase I;
Early-Stage Clinical Trials;
Phase 1 Study;
Phase I Clinical Trials;
Phase I Protocol;
Phase I Study;
phase I trial;
Trial Phase 1 =Research Activity =clinical trial;
55. St. Regis Band of Mohawk Indians of New York
(UMLS (HL7) C1554506) =Population Group =NativeEntityContiguous;
6. 1ST DEG BURN ABDOMN WALL
[ ] (UMLS (ICD9CM) C0840797) Erythema due to burn [first degree] of abdominal wall =Injury or Poisoning
56. ST13
[This gene is involved in the mediation of protein-protein interactions. ( NCI )] (UMLS (NCI) C1337104) ST13 Gene;
Suppression of Tumorigenicity 13 (Colon Carcinoma) (Hsp70 Interacting Protein) Gene;
=Gene or Genome ;
7. 1ST DEG BURN ANKLE
[ ] (UMLS (ICD9CM) C0161274) =Injury or Poisoning
57. ST14
[This gene is involved in the activation of proteases and latent growth factors in epithelial membranes. ( NCI )] (UMLS (NCI) C1366520) ST14 Gene;
Suppression of Tumorigenicity 14 (Colon Carcinoma, Matriptase, Epithin) Gene =Gene or Genome
8. 1ST DEG BURN ARM NOS
[ ] (UMLS (ICD9CM) C0161157) =Injury or Poisoning
58. ST5
[This gene plays a role in signal transduction and tumor suppression. ( NCI )] (UMLS (NCI) C0812376) ST5 Gene;
Suppression of Tumorigenicity 5 Gene =Gene or Genome ;
9. 1ST DEG BURN ARM-MULT
[ ] (UMLS (ICD9CM) C0161164) =Injury or Poisoning
59. ST7
[Widely expressed as different isoforms in nonepithelial tissues (heart, skeletal muscle, brain, lung, placenta and pancreas) by human ST7 Gene, highly conserved 859-aa 95-kDa Suppression of Tumorigenicity 7 Protein is a likely type II membrane protein, containing 2 CUB domains and 5 LDL-R Class A domains, that may act as a tumor suppressor. (NCI) ( NCI )] (UMLS (NCI) C0916548) Suppression of Tumorigenicity 7 Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
10. 1ST DEG BURN AXILLA
[ ] (UMLS (ICD9CM) C0161161) =Injury or Poisoning
60. ST7
[This gene plays a putative role in the negative regulation of cell growth. ( NCI )] (UMLS (NCI) C1420445) ST7 Gene;
Suppression of Tumorigenicity 7 Gene =Gene or Genome
11. 1ST DEG BURN BACK
[ ] (UMLS (ICD9CM) C0840798) Erythema due to burn [first degree] of back [any part] =Injury or Poisoning
61. Stability
[The quality of being free from change or variation or not taking part readily in chemical change. ( NCI )] (UMLS (NCI) C0205360) =Qualitative Concept
12. 1ST DEG BURN BREAST
[ ] (UMLS (ICD9CM) C0161109) =Injury or Poisoning
62. stabilizer
[A stabilizer (player) added to a mixture (scoper) in order to prevent the molecular disintegration of the main substance. ( HL7V3.0 )] (UMLS (HL7) C1550603) =Substance =inactive ingredient;
13. 1ST DEG BURN CHEST WALL
[ ] (UMLS (ICD9CM) C0161110) =Injury or Poisoning
63. Stable
(UMLS (HL7) C1547311) =Intellectual Product =Patient Condition Code;
14. 1ST DEG BURN CHIN
[ ] (UMLS (ICD9CM) C0433307) =Injury or Poisoning
64. Stable Angina
[Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration or oral, sublingual or transdermal antianginal medications. ( NCI )] (UMLS (NCI) C0340288) =Disease or Syndrome
15. 1ST DEG BURN EAR
[ ] (UMLS (ICD9CM) C0161046) =Injury or Poisoning
65. stable cell line
[ ] (UMLS (CSP) C0598091) =Cell ;
16. 1ST DEG BURN ELBOW
[ ] (UMLS (ICD9CM) C0161159) =Injury or Poisoning
66. stable disease
[Cancer that is neither decreasing nor increasing in extent or severity. ( NCI )] (UMLS (NCI) C0677946) =Finding
17. 1ST DEG BURN EYE
[ ] (UMLS (ICD9CM) C0161047) =Injury or Poisoning
67. stable fly
[ ] (UMLS (CSP) C0038371) =Invertebrate ;
18. 1ST DEG BURN FACE NEC
[ ] (UMLS (ICD9CM) C0161052) =Injury or Poisoning
68. stable isotope
[does not undergo radioactive decay; index specific element that is being tagged; index with a specific element when appropriate, e.g., C13 index with CARBON and STABLE ISOTOPE. ( CSP )] (UMLS (CSP) C0302918) =Element, Ion, or Isotope =Element;
=deuterium
19. 1ST DEG BURN FINGER
[ ] (UMLS (ICD9CM) C0161213) =Injury or Poisoning
69. stable isotope diagnosis
[determination of the presence of a disease(s) or condition or the distinguishing of one disease or condition from another using a nonradioactive nuclide, an isotope that shows no tendency to undergo radioactive decomposition. ( CSP )] (UMLS (CSP) C0597506) =Diagnostic Procedure =radiodiagnosis;
20. 1ST DEG BURN FOOT
[ ] (UMLS (ICD9CM) C0161273) =Injury or Poisoning
70. stable isotope double label
[ ] (UMLS (CSP) C0597507) =Laboratory Procedure =nuclear magnetic resonance spectroscopy;
21. 1ST DEG BURN FOREARM
[ ] (UMLS (ICD9CM) C0161158) =Injury or Poisoning
71. Stachybotrys
[A mitosporic fungal genus including one species which forms a toxin in moldy hay that may cause a serious illness in horses. ( MSH )] (UMLS (CSP) C0038118) =Fungus
22. 1ST DEG BURN GENITALIA
[ ] (UMLS (ICD9CM) C0161113) =Injury or Poisoning
72. STAF28
[Encoded by human TAF10 Gene (TAF2H Family), 218-aa nuclear Transcription Initiation Factor TFIID 30 kDa Subunit is a small subunit of TFIID and associated with a subset of TFIID complexes. A component of the PCAF complex, the TFTC-HAT complex, and the STAGA transcription coactivator-HAT complex, TAF10 is required for transcriptional activation by estrogen receptor, for cell cycle progression, and may be required for some cell differentiation programs. TFIID is composed of TBP and many evolutionarily conserved TAFs, which participate in basal transcription, serve as coactivators, and function in promoter recognition or modify general transcription factors to facilitate complex assembly and transcription initiation. Multimeric protein complex TFIID binds to the core promoter to position polymerase, serves as scaffold for assembly of the transcription complex, and acts as a channel for regulatory signals. ( NCI )] (UMLS (NCI) C0289408) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
23. 1ST DEG BURN HAND NOS
[ ] (UMLS (ICD9CM) C0274090) =Injury or Poisoning
73. staff
[Courtesies extended to the staff of the entity providing service. ( HL7V3.0 )] (UMLS (HL7) C1551040) =Idea or Concept =EncounterSpecialCourtesy;
24. 1ST DEG BURN HAND-MULT
[ ] (UMLS (ICD9CM) C0161220) =Injury or Poisoning
74. Staff
[The employees of an organization; personnel who assist their superior in carrying out an assigned task. ( NCI )] (UMLS (NCI) C0851286) =Professional or Occupational Group ;
25. 1ST DEG BURN HEAD NOS
[ ] (UMLS (ICD9CM) C0273941) =Injury or Poisoning
75. Staff Family Member
[Family member of staff member ( HL7V3.0 )] (UMLS (HL7) C1552088) =Idea or Concept =PatientImportance;
26. 1ST DEG BURN HEAD-MULT
[ ] (UMLS (ICD9CM) C0161054) =Injury or Poisoning
76. Staff master file
(UMLS (HL7) C1549589) =Intellectual Product =Master file identifier code;
27. 1ST DEG BURN KNEE
[ ] (UMLS (ICD9CM) C0161276) =Injury or Poisoning
77. Staff Member
[Staff member of the health care organization ( HL7V3.0 )] (UMLS (HL7) C1552089) =Idea or Concept =PatientImportance;
28. 1ST DEG BURN LEG NOS
[ ] (UMLS (ICD9CM) C0161271) =Injury or Poisoning
78. Staff Physician
[Member of the health care organization physician staff ( HL7V3.0 )] (UMLS (HL7) C1552084) =Qualitative Concept =PatientImportance;
29. 1ST DEG BURN LEG-MULT
[ ] (UMLS (ICD9CM) C0161278) =Injury or Poisoning
79. Staff type
(UMLS (HL7) C1547600) =Professional or Occupational Group =HL7 Vocabulary Version 2.5;
=No suggested values defined
30. 1ST DEG BURN LIP
[ ] (UMLS (ICD9CM) C0161048) =Injury or Poisoning
80. Staffordshire Bull Terrier
[The Staffordshire Bull Terrier is a powerful and muscular dog, very strong for his size with a broad head and very strong jaws. The ears are either rose or half-pricked. The short coat is soft and close and comes in black, blue, fawn or brindle, often with white markings. Height: 13-16 inches (33-41 cm.) Weight: 23-38 pounds (11-17 kg.) ( NCI )] (UMLS (NCI) C0324325) =Mammal
31. 1ST DEG BURN LOWER LEG
[ ] (UMLS (ICD9CM) C0161275) =Injury or Poisoning
81. stage
[The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body. ( NCI )] (UMLS (NCI) C1300072) T-Stage;
Tumor Stage;
=Clinical Attribute
32. 1ST DEG BURN MULT FINGER
[ ] (UMLS (ICD9CM) C0161215) =Injury or Poisoning
82. Stage
[Any distinct time period in a sequence of events. ( NCI )] (UMLS (NCI) C1306673) =Qualitative Concept ;
33. 1ST DEG BURN MULT SITE
[ ] (UMLS (ICD9CM) C0161316) =Injury or Poisoning
83. Stage 0
(UMLS (NCI) C0441763) =Intellectual Product
34. 1ST DEG BURN NECK
[ ] (UMLS (ICD9CM) C0161053) =Injury or Poisoning
84. Stage 0 AIDS-Related Anal Canal Cancer
(UMLS (NCI) C1336087) =Neoplastic Process
35. 1ST DEG BURN NOSE
[ ] (UMLS (ICD9CM) C0161050) =Injury or Poisoning
85. Stage 0 Bladder Adenocarcinoma
[Stage 0 includes Ta,Tis,N0,M0. Ta: Noninvasive papillary carcinoma. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis (PDQ) ( NCI )] (UMLS (NCI) C0855175) =Neoplastic Process
36. 1ST DEG BURN PALM
[ ] (UMLS (ICD9CM) C0161217) =Injury or Poisoning
86. Stage 0 Bladder Squamous Cell Carcinoma
[Staging is by TNM classification. Stage O would include Ta NO MO. Ta: Noninvasive papillary carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis ( NCI )] (UMLS (NCI) C0855187) Stage 0 Squamous Cell Carcinoma of Bladder;
Stage 0 Squamous Cell Carcinoma of the Bladder;
=Neoplastic Process
37. 1ST DEG BURN SCALP
[ ] (UMLS (ICD9CM) C0375673) =Injury or Poisoning
87. Stage 0 Cancer of Testis
[Stage 0 includes: pTis, N0, M0, S0. pTis: Intratubular germ cell neoplasia (carcinoma in situ). N0: regional lymph node metastasis. M0: No distant metastasis. S0: Marker study levels within normal limits. (AJCC 6th ed) - 2003 ( NCI )] (UMLS (NCI) C0346237) =Neoplastic Process
38. 1ST DEG BURN SCAPULA
[ ] (UMLS (ICD9CM) C0161163) =Injury or Poisoning
88. Stage 0 Carcinoma of Penis
[Stage 0 includes: (Tis, N0, M0) and (Ta, N0, M0). Tis: Carcinoma in situ. Ta: Non-invasive verrucous carcinoma. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1321897) Stage 0 Carcinoma of the Penis;
Stage 0 Penile Cancer;
Stage 0 Penile Carcinoma =Neoplastic Process ;
39. 1ST DEG BURN SHOULDER
[ ] (UMLS (ICD9CM) C0161162) =Injury or Poisoning
89. Stage 0 Carcinoma of Renal Pelvis
[Stage 0 includes: 0a: (Ta, N0, M0) and 0is: (Tis, N0, M0). T0: No evidence of primary tumor. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th ed.) - 2003 ( NCI )] (UMLS (NCI) C1336094) Stage 0 Carcinoma of the Renal Pelvis;
Stage 0 Renal Pelvis Urothelial Carcinoma;
=Neoplastic Process
40. 1ST DEG BURN THIGH
[ ] (UMLS (ICD9CM) C0161277) =Injury or Poisoning
90. Stage 0 Carcinoma of the Ureter
(UMLS (NCI) C1336098) Stage 0 Carcinoma of Ureter;
Stage 0 Ureter Carcinoma;
Stage 0 Ureter Urothelial Carcinoma;
Stage 0 Ureteral Carcinoma;
Ureter Cancer Stage 0 =Neoplastic Process
41. 1ST DEG BURN THUMB
[ ] (UMLS (ICD9CM) C0161214) =Injury or Poisoning
91. Stage 0 Carcinoma of the Urethra
(UMLS (NCI) C1336099) Stage 0 Carcinoma of Urethra;
Stage 0 Urethra Cancer;
Stage 0 Urethra Carcinoma;
Stage 0 Urethral Cancer;
Stage 0 Urethral Carcinoma;
Urethra Cancer Stage 0;
=Neoplastic Process
42. 1ST DEG BURN TOE
[ ] (UMLS (ICD9CM) C0161272) =Injury or Poisoning
92. Stage 0 Large Cell Carcinoma of Lung
(UMLS (NCI) C0854978) Stage 0 Large Cell Carcinoma of the Lung;
Stage 0 Large Cell Lung Cancer;
Stage 0 Large Cell Lung Carcinoma;
=Neoplastic Process
43. 1ST DEG BURN TRUNK NEC
[ ] (UMLS (ICD9CM) C0161114) =Injury or Poisoning
93. Stage 0 Rectosigmoid Cancer
[Stage 0 includes Tis,N0,M0. Tis: Carcinoma in situ: intraepithelial or invasion of the lamina propria. N0: No regional lymph node metastasis. M0: No distant metastasis (PDQ) ( NCI )] (UMLS (NCI) C0854780) Stage 0 Rectosigmoid Carcinoma;
=Neoplastic Process
44. 1ST DEG BURN TRUNK NOS
[ ] (UMLS (ICD9CM) C0840795) Erythema due to burn [first degree] of unspecified site of trunk =Injury or Poisoning
94. Stage 0 Seminoma
(UMLS (NCI) C1336095) =Neoplastic Process
45. 1ST DEG BURN UPPER ARM
[ ] (UMLS (ICD9CM) C0161160) =Injury or Poisoning
95. Stage 0 Transitional Cell Carcinoma
(UMLS (NCI) C0334267) =Neoplastic Process
46. 1ST DEG BURN WRIST
[ ] (UMLS (ICD9CM) C0274084) =Injury or Poisoning
96. Stage 0a
(UMLS (NCI) C0441764) =Intellectual Product
47. 1ST DEGREE BURN NOS
[ ] (UMLS (ICD9CM) C0332686) =Injury or Poisoning
97. Stage 0a Carcinoma of the Ureter
(UMLS (NCI) C1336102) Stage 0a Carcinoma of Ureter;
Stage 0a Ureter Carcinoma;
Stage 0a Ureter Urothelial Carcinoma;
Stage 0a Ureteral Carcinoma;
Ureter Cancer Stage 0a;
Ureter Papillary Noninvasive Carcinoma;
=Neoplastic Process
48. 1st non-Operative
(UMLS (HL7) C1547204) =Idea or Concept =Procedure DRG Type;
98. Stage 0a Carcinoma of the Urethra
(UMLS (NCI) C1336103) Stage 0a Carcinoma of Urethra;
Stage 0a Urethra Cancer;
Stage 0a Urethra Carcinoma;
Stage 0a Urethral Cancer;
Stage 0a Urethral Carcinoma;
Urethra Cancer Stage 0a;
=Neoplastic Process
49. 2
[A study to test whether a new treatment has an anticancer effect (for example, whether it shrinks a tumor or improves blood test results) and whether it works against a certain type of cancer. ( NCI )] (UMLS (NCI) C0282460) study II =Research Activity ;
=clinical trial;
99. Stage 0a Renal Pelvis and Ureter Cancer
(UMLS (NCI) C1336101) Stage 0a Renal Pelvis and Ureter Urothelial Carcinoma =Neoplastic Process
50. 3
[A study to compare the results of people taking a new treatment with the results of people taking the standard treatment (for example, which group has better survival rates or fewer side effects). In most cases, studies move into phase III only after a treatment seems to work in phases I and II. Phase III trials may include hundreds of people. ( NCI )] (UMLS (NCI) C0282461) study III =Research Activity ;
=clinical trial;
100. Stage 0is
(UMLS (NCI) C0441765) =Intellectual Product

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM